IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (V-SET AND IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN 9)) HUMANIZED MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-448) (HOMO SAPIENS VH (IGHV4-38-2*01 (89%) (IGHD)-IGHJ4*01 (93%) (9.7.11) (1-118) -HOMO SAPIENS IGHG1*03) (119-448) (221-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-33*01 (85%) IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*05 (108'-214')), DIMER (227-227'':230-230'')-BISDISULFIDE)
Locally Advanced Cancer
OncoMed Pharmaceuticals, Inc.monoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Locally Advanced Cancer cohort.
Same molecule, other indications
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS T-CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS (V-SET AND IMMUNOGLOBULIN DOMAIN-CONTAINING PROTEIN 9)) HUMANIZED MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-448) (HOMO SAPIENS VH (IGHV4-38-2*01 (89%) (IGHD)-IGHJ4*01 (93%) (9.7.11) (1-118) -HOMO SAPIENS IGHG1*03) (119-448) (221-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV1-33*01 (85%) IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*05 (108'-214')), DIMER (227-227'':230-230'')-BISDISULFIDE) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →